A New Dawn for Inhalable Insulin?

| Oct 12, 2013

Few treatments for type 1 diabetes have been as elusive and long-promised as inhalable insulin. The concept has always sounded remarkable: Instead of jabbing themselves with needles, type 1s (and insulin-using type 2s) could take a quick puff on an inhaler to get a dose of insulin.

Exubera, a brand of inhalable insulin made by Pfizer, was briefly on sale in 2006 and 2007, before being withdrawn. But the MannKind Corporation hasn't let the past dampen its enthusiasm for the product's future. MannKind currently is working with a new type of inhalable insulin, called Afrezza.

According to the company, the insulin works especially quickly: Peak levels "are achieved within 12 to 14 minutes of administration, effectively mimicking the release of meal-time insulin observed in healthy individuals, but which is absent in patients with diabetes."

But no inhalable insulin can work on its own, which is why MannKind has also developed a next-generation insulin inhaler that they call the Dreamboat. The combination of insulin and inhaler has just been tested in a phase three clinical study. And the news was good-patients showed A1c decreases, reductions in hypoglycemia, and lower fasting blood sugar levels.

"We are pleased that (the study) met its primary endpoint of non-inferiority, by demonstrating that Afrezza produces A1c reductions comparable to insulin aspart," said Alfred Mann, chairman and CEO of MannKind.

"Based on the results of this study, we believe that Afrezza can be used to achieve glycemic control that is comparable to the current standard of care while at the same time offering potential advantages in terms of lower fasting blood glucose levels, weight neutrality, and a lower overall risk of hypoglycemia."

These results are still early, and work remains to be done before bringing the treatment to market. (If you're interested in more details about the study, follow the link below.) But more options to treat diabetes are welcome, especially ones that help remove the pain and fear that needles can cause.

Sources:

http://www.businesswire.com/news/home/20130814005343/en

http://www.bloomberg.com/video/diabetics-hold-their-breath-for-inhalable-insulin-gJnWZLaySOifyZ7QemVkaw.html

Click Here To View Or Post Comments

Categories: A1c Reductions, Afrezza, Exubera, Glycemic Control, Hypoglycemia, Inhalable Insulin, Insulin Aspart, MannKind, Pfizer, Type 1


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • What's on the Horizon with Diabetes Research and Therapy
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Comments


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.